BridgeMD
Prevention study for Diabetes Mellitus, Type 2
Official title Regular Use of aPDT in the Management and Prevention of Periodontitis Symptoms in Diabetic Patients
ClinicalTrials.gov ID: NCT06486012
What this study is testing
- What it's testing
- This is an investigator-initiated clinical study to establish easy referral and access for diabetic patients from primary health care to oral health care facilities for preventive oral care, periodontal assessment, and treatment, and to investigate the impact of regular home use of aPDT medical device on plaque control and gingival health, when used as an adjunct treatment to standard oral hygiene, and the effect on diabetes control in patients with the risk of periodontal disease, compared to a standard home care oral hygiene regimen.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diabetic patient treated at community health care;
- At least 18 years old;
- Presence of ≥20 teeth;
- Agreement to participate in the study, and to sign a written consent form;
- Ability to cooperate with the treatment protocol according to coordinator investigator's assessment.
You likely can't join if
- Oral thrush;
- Known sensitivity to near-infrared or antibacterial blue light.
The study team makes the final eligibility decision.
Where it's taking place
- Tampere, Pirkanmaa, Finland
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tampere, Pirkanmaa, Finland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.